3-amino-N-[6-[2-(5-cyclopropyl-1,2-oxazol-3-yl)-2-oxoethyl]-2-bicyclo[3.3.1]nonanyl]propanamide;N-[cyclohexyl-[3-[(3-methylphenyl)methylcarbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;N-[cyclohexyl-[3-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[1-(1H-indol-4-yl)-2,2-dimethylpropyl]-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[(1-oxo-2-phenyl-3,4-dihydroisoquinolin-5-yl)-piperidin-4-ylmethyl]-1,2-oxazole-3-carboxamide

C126H155N17O14 — CID 158634548

IUPAC3-amino-N-[6-[2-(5-cyclopropyl-1,2-oxazol-3-yl)-2-oxoethyl]-2-bicyclo[3.3.1]nonanyl]propanamide;N-[cyclohexyl-[3-[(3-methylphenyl)methylcarbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;N-[cyclohexyl-[3-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[1-(1H-indol-4-yl)-2,2-dimethylpropyl]-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[(1-oxo-2-phenyl-3,4-dihydroisoquinolin-5-yl)-piperidin-4-ylmethyl]-1,2-oxazole-3-carboxamide
SMILESCC(C)(C)C(NC(=O)c1cc(C2CC2)on1)c1cccc2[nH]ccc12.CC(C)N1CCC(NC(=O)c2cccc(C(NC(=O)c3cc(C4CC4)on3)C3CCCCC3)c2)CC1.Cc1cccc(CNC(=O)c2cccc(C(NC(=O)c3cc(C4CC4)on3)C3CCCCC3)c2)c1.NCCC(=O)NC1CCC2CC1CCC2CC(=O)c1cc(C2CC2)on1.O=C(NC(c1cccc2c1CCN(c1ccccc1)C2=O)C1CCNCC1)c1cc(C2CC2)on1
InChIInChI=1S/C29H40N4O3.C29H33N3O3.C28H30N4O3.C20H29N3O3.C20H23N3O2/c1-19(2)33-15-13-24(14-16-33)30-28(34)23-10-6-9-22(17-23)27(21-7-4-3-5-8-21)31-29(35)25-18-26(36-32-25)20-11-12-20;1-19-7-5-8-20(15-19)18-30-28(33)24-12-6-11-23(16-24)27(22-9-3-2-4-10-22)31-29(34)25-17-26(35-32-25)21-13-14-21;33-27(24-17-25(35-31-24)18-9-10-18)30-26(19-11-14-29-15-12-19)22-7-4-8-23-21(22)13-16-32(28(23)34)20-5-2-1-3-6-20;21-8-7-20(25)22-16-6-5-13-9-15(16)4-3-14(13)10-18(24)17-11-19(26-23-17)12-1-2-12;1-20(2,3)18(14-5-4-6-15-13(14)9-10-21-15)22-19(24)16-11-17(25-23-16)12-7-8-12/h6,9-10,17-21,24,27H,3-5,7-8,11-16H2,1-2H3,(H,30,34)(H,31,35);5-8,11-12,15-17,21-22,27H,2-4,9-10,13-14,18H2,1H3,(H,30,33)(H,31,34);1-8,17-19,26,29H,9-16H2,(H,30,33);11-16H,1-10,21H2,(H,22,25);4-6,9-12,18,21H,7-8H2,1-3H3,(H,22,24)
InChIKeyHZPNJZRCGGFQQB-UHFFFAOYSA-N
MW2131.73 g/mol
LogP22.61
Rot. Bonds33

About 3-amino-N-[6-[2-(5-cyclopropyl-1,2-oxazol-3-yl)-2-oxoethyl]-2-bicyclo[3.3.1]nonanyl]propanamide;N-[cyclohexyl-[3-[(3-methylphenyl)methylcarbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;N-[cyclohexyl-[3-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[1-(1H-indol-4-yl)-2,2-dimethylpropyl]-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[(1-oxo-2-phenyl-3,4-dihydroisoquinolin-5-yl)-piperidin-4-ylmethyl]-1,2-oxazole-3-carboxamide

3-amino-N-[6-[2-(5-cyclopropyl-1,2-oxazol-3-yl)-2-oxoethyl]-2-bicyclo[3.3.1]nonanyl]propanamide;N-[cyclohexyl-[3-[(3-methylphenyl)methylcarbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;N-[cyclohexyl-[3-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[1-(1H-indol-4-yl)-2,2-dimethylpropyl]-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[(1-oxo-2-phenyl-3,4-dihydroisoquinolin-5-yl)-piperidin-4-ylmethyl]-1,2-oxazole-3-carboxamide (PubChem CID 158634548) has the molecular formula C126H155N17O14 and a molecular weight of 2131.73 g/mol. Its IUPAC name is 3-amino-N-[6-[2-(5-cyclopropyl-1,2-oxazol-3-yl)-2-oxoethyl]-2-bicyclo[3.3.1]nonanyl]propanamide;N-[cyclohexyl-[3-[(3-methylphenyl)methylcarbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;N-[cyclohexyl-[3-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[1-(1H-indol-4-yl)-2,2-dimethylpropyl]-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[(1-oxo-2-phenyl-3,4-dihydroisoquinolin-5-yl)-piperidin-4-ylmethyl]-1,2-oxazole-3-carboxamide.

Molecular Properties

Compound Name3-amino-N-[6-[2-(5-cyclopropyl-1,2-oxazol-3-yl)-2-oxoethyl]-2-bicyclo[3.3.1]nonanyl]propanamide;N-[cyclohexyl-[3-[(3-methylphenyl)methylcarbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;N-[cyclohexyl-[3-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[1-(1H-indol-4-yl)-2,2-dimethylpropyl]-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[(1-oxo-2-phenyl-3,4-dihydroisoquinolin-5-yl)-piperidin-4-ylmethyl]-1,2-oxazole-3-carboxamide
PubChem CID158634548
Molecular FormulaC126H155N17O14
Molecular Weight2131.73 g/mol
Exact Mass2130.19
IUPAC Name3-amino-N-[6-[2-(5-cyclopropyl-1,2-oxazol-3-yl)-2-oxoethyl]-2-bicyclo[3.3.1]nonanyl]propanamide;N-[cyclohexyl-[3-[(3-methylphenyl)methylcarbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;N-[cyclohexyl-[3-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[1-(1H-indol-4-yl)-2,2-dimethylpropyl]-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[(1-oxo-2-phenyl-3,4-dihydroisoquinolin-5-yl)-piperidin-4-ylmethyl]-1,2-oxazole-3-carboxamide
SMILESCC(C)(C)C(NC(=O)c1cc(C2CC2)on1)c1cccc2[nH]ccc12.CC(C)N1CCC(NC(=O)c2cccc(C(NC(=O)c3cc(C4CC4)on3)C3CCCCC3)c2)CC1.Cc1cccc(CNC(=O)c2cccc(C(NC(=O)c3cc(C4CC4)on3)C3CCCCC3)c2)c1.NCCC(=O)NC1CCC2CC1CCC2CC(=O)c1cc(C2CC2)on1.O=C(NC(c1cccc2c1CCN(c1ccccc1)C2=O)C1CCNCC1)c1cc(C2CC2)on1
InChIInChI=1S/C29H40N4O3.C29H33N3O3.C28H30N4O3.C20H29N3O3.C20H23N3O2/c1-19(2)33-15-13-24(14-16-33)30-28(34)23-10-6-9-22(17-23)27(21-7-4-3-5-8-21)31-29(35)25-18-26(36-32-25)20-11-12-20;1-19-7-5-8-20(15-19)18-30-28(33)24-12-6-11-23(16-24)27(22-9-3-2-4-10-22)31-29(34)25-17-26(35-32-25)21-13-14-21;33-27(24-17-25(35-31-24)18-9-10-18)30-26(19-11-14-29-15-12-19)22-7-4-8-23-21(22)13-16-32(28(23)34)20-5-2-1-3-6-20;21-8-7-20(25)22-16-6-5-13-9-15(16)4-3-14(13)10-18(24)17-11-19(26-23-17)12-1-2-12;1-20(2,3)18(14-5-4-6-15-13(14)9-10-21-15)22-19(24)16-11-17(25-23-16)12-7-8-12/h6,9-10,17-21,24,27H,3-5,7-8,11-16H2,1-2H3,(H,30,34)(H,31,35);5-8,11-12,15-17,21-22,27H,2-4,9-10,13-14,18H2,1H3,(H,30,33)(H,31,34);1-8,17-19,26,29H,9-16H2,(H,30,33);11-16H,1-10,21H2,(H,22,25);4-6,9-12,18,21H,7-8H2,1-3H3,(H,22,24)
InChIKeyHZPNJZRCGGFQQB-UHFFFAOYSA-N
XLogP22.61
TPSA428.31 Ų
H-Bond Donors10
H-Bond Acceptors22
Rotatable Bonds33
Heavy Atoms157
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002131.73
LogP ≤ 522.61
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1022

Analyze 3-amino-N-[6-[2-(5-cyclopropyl-1,2-oxazol-3-yl)-2-oxoethyl]-2-bicyclo[3.3.1]nonanyl]propanamide;N-[cyclohexyl-[3-[(3-methylphenyl)methylcarbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;N-[cyclohexyl-[3-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[1-(1H-indol-4-yl)-2,2-dimethylpropyl]-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[(1-oxo-2-phenyl-3,4-dihydroisoquinolin-5-yl)-piperidin-4-ylmethyl]-1,2-oxazole-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-amino-N-[6-[2-(5-cyclopropyl-1,2-oxazol-3-yl)-2-oxoethyl]-2-bicyclo[3.3.1]nonanyl]propanamide;N-[cyclohexyl-[3-[(3-methylphenyl)methylcarbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;N-[cyclohexyl-[3-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[1-(1H-indol-4-yl)-2,2-dimethylpropyl]-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[(1-oxo-2-phenyl-3,4-dihydroisoquinolin-5-yl)-piperidin-4-ylmethyl]-1,2-oxazole-3-carboxamide?
The IUPAC name of 3-amino-N-[6-[2-(5-cyclopropyl-1,2-oxazol-3-yl)-2-oxoethyl]-2-bicyclo[3.3.1]nonanyl]propanamide;N-[cyclohexyl-[3-[(3-methylphenyl)methylcarbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;N-[cyclohexyl-[3-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[1-(1H-indol-4-yl)-2,2-dimethylpropyl]-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[(1-oxo-2-phenyl-3,4-dihydroisoquinolin-5-yl)-piperidin-4-ylmethyl]-1,2-oxazole-3-carboxamide (CID 158634548) is 3-amino-N-[6-[2-(5-cyclopropyl-1,2-oxazol-3-yl)-2-oxoethyl]-2-bicyclo[3.3.1]nonanyl]propanamide;N-[cyclohexyl-[3-[(3-methylphenyl)methylcarbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;N-[cyclohexyl-[3-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[1-(1H-indol-4-yl)-2,2-dimethylpropyl]-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[(1-oxo-2-phenyl-3,4-dihydroisoquinolin-5-yl)-piperidin-4-ylmethyl]-1,2-oxazole-3-carboxamide.
What is the SMILES notation for 3-amino-N-[6-[2-(5-cyclopropyl-1,2-oxazol-3-yl)-2-oxoethyl]-2-bicyclo[3.3.1]nonanyl]propanamide;N-[cyclohexyl-[3-[(3-methylphenyl)methylcarbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;N-[cyclohexyl-[3-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[1-(1H-indol-4-yl)-2,2-dimethylpropyl]-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[(1-oxo-2-phenyl-3,4-dihydroisoquinolin-5-yl)-piperidin-4-ylmethyl]-1,2-oxazole-3-carboxamide?
The canonical SMILES for 3-amino-N-[6-[2-(5-cyclopropyl-1,2-oxazol-3-yl)-2-oxoethyl]-2-bicyclo[3.3.1]nonanyl]propanamide;N-[cyclohexyl-[3-[(3-methylphenyl)methylcarbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;N-[cyclohexyl-[3-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[1-(1H-indol-4-yl)-2,2-dimethylpropyl]-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[(1-oxo-2-phenyl-3,4-dihydroisoquinolin-5-yl)-piperidin-4-ylmethyl]-1,2-oxazole-3-carboxamide is CC(C)(C)C(NC(=O)c1cc(C2CC2)on1)c1cccc2[nH]ccc12.CC(C)N1CCC(NC(=O)c2cccc(C(NC(=O)c3cc(C4CC4)on3)C3CCCCC3)c2)CC1.Cc1cccc(CNC(=O)c2cccc(C(NC(=O)c3cc(C4CC4)on3)C3CCCCC3)c2)c1.NCCC(=O)NC1CCC2CC1CCC2CC(=O)c1cc(C2CC2)on1.O=C(NC(c1cccc2c1CCN(c1ccccc1)C2=O)C1CCNCC1)c1cc(C2CC2)on1.
What is the InChIKey of 3-amino-N-[6-[2-(5-cyclopropyl-1,2-oxazol-3-yl)-2-oxoethyl]-2-bicyclo[3.3.1]nonanyl]propanamide;N-[cyclohexyl-[3-[(3-methylphenyl)methylcarbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;N-[cyclohexyl-[3-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[1-(1H-indol-4-yl)-2,2-dimethylpropyl]-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[(1-oxo-2-phenyl-3,4-dihydroisoquinolin-5-yl)-piperidin-4-ylmethyl]-1,2-oxazole-3-carboxamide?
The InChIKey is HZPNJZRCGGFQQB-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H40N4O3.C29H33N3O3.C28H30N4O3.C20H29N3O3.C20H23N3O2/c1-19(2)33-15-13-24(14-16-33)30-28(34)23-10-6-9-22(17-23)27(21-7-4-3-5-8-21)31-29(35)25-18-26(36-32-25)20-11-12-20;1-19-7-5-8-20(15-19)18-30-28(33)24-12-6-11-23(16-24)27(22-9-3-2-4-10-22)31-29(34)25-17-26(35-32-25)21-13-14-21;33-27(24-17-25(35-31-24)18-9-10-18)30-26(19-11-14-29-15-12-19)22-7-4-8-23-21(22)13-16-32(28(23)34)20-5-2-1-3-6-20;21-8-7-20(25)22-16-6-5-13-9-15(16)4-3-14(13)10-18(24)17-11-19(26-23-17)12-1-2-12;1-20(2,3)18(14-5-4-6-15-13(14)9-10-21-15)22-19(24)16-11-17(25-23-16)12-7-8-12/h6,9-10,17-21,24,27H,3-5,7-8,11-16H2,1-2H3,(H,30,34)(H,31,35);5-8,11-12,15-17,21-22,27H,2-4,9-10,13-14,18H2,1H3,(H,30,33)(H,31,34);1-8,17-19,26,29H,9-16H2,(H,30,33);11-16H,1-10,21H2,(H,22,25);4-6,9-12,18,21H,7-8H2,1-3H3,(H,22,24).
What are the key properties of 3-amino-N-[6-[2-(5-cyclopropyl-1,2-oxazol-3-yl)-2-oxoethyl]-2-bicyclo[3.3.1]nonanyl]propanamide;N-[cyclohexyl-[3-[(3-methylphenyl)methylcarbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;N-[cyclohexyl-[3-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[1-(1H-indol-4-yl)-2,2-dimethylpropyl]-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[(1-oxo-2-phenyl-3,4-dihydroisoquinolin-5-yl)-piperidin-4-ylmethyl]-1,2-oxazole-3-carboxamide?
3-amino-N-[6-[2-(5-cyclopropyl-1,2-oxazol-3-yl)-2-oxoethyl]-2-bicyclo[3.3.1]nonanyl]propanamide;N-[cyclohexyl-[3-[(3-methylphenyl)methylcarbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;N-[cyclohexyl-[3-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[1-(1H-indol-4-yl)-2,2-dimethylpropyl]-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[(1-oxo-2-phenyl-3,4-dihydroisoquinolin-5-yl)-piperidin-4-ylmethyl]-1,2-oxazole-3-carboxamide has a molecular weight of 2131.73 g/mol, XLogP of 22.61, 33 rotatable bonds, 10 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for 3-amino-N-[6-[2-(5-cyclopropyl-1,2-oxazol-3-yl)-2-oxoethyl]-2-bicyclo[3.3.1]nonanyl]propanamide;N-[cyclohexyl-[3-[(3-methylphenyl)methylcarbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;N-[cyclohexyl-[3-[(1-propan-2-ylpiperidin-4-yl)carbamoyl]phenyl]methyl]-5-cyclopropyl-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[1-(1H-indol-4-yl)-2,2-dimethylpropyl]-1,2-oxazole-3-carboxamide;5-cyclopropyl-N-[(1-oxo-2-phenyl-3,4-dihydroisoquinolin-5-yl)-piperidin-4-ylmethyl]-1,2-oxazole-3-carboxamide is sourced from PubChem (CID 158634548), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).